Actuary vs Business Analyst salary
In Indonesia, a actuary earns about 60% more than a business analyst — $28,972 vs $18,099 per year.
Showing amounts in USD (USD default; source data is IDR). FX as of Mon, 13 Jul 2026 00:02:31 +0000. Convert currencies
Pays more
Finance & Business
Actuary$28,972/yr
- Monthly
- $2,414
- Hourly
- $14
- Range
- $19,064–$41,083
- 10-yr outlook
- +22%
Finance & Business
Business Analyst$18,099/yr
- Monthly
- $1,508
- Hourly
- $9
- Range
- $11,909–$25,664
- 10-yr outlook
- +10%
Pay range, side by side
| Percentile | Actuary | Business Analyst |
|---|---|---|
| Entry (10th) | $19,064 | $11,909 |
| 25th | $24,018 | $15,004 |
| Median | $28,972 | $18,099 |
| 75th | $35,027 | $21,882 |
| Senior (90th) | $41,083 | $25,664 |
National Indonesia figures in IDR. Individual pay varies with experience, employer, and location.
More Finance & Business comparisons
Frequently asked questions
- Does a actuary or business analyst earn more in Indonesia?
- A actuary earns more, at about Rp 523.560.000 per year vs Rp 327.070.000 for a business analyst — roughly 60% (Rp 196.490.000) more.
- What is the salary range for these roles in Indonesia?
- A actuary typically earns Rp 344.502.500–Rp 742.408.100, while a business analyst earns Rp 215.212.100–Rp 463.785.300 per year.
- How much do these jobs pay per month in Indonesia?
- On a monthly basis before tax, a actuary averages about Rp 43.630.000 and a business analyst about Rp 27.255.800.
- How do entry-level salaries compare?
- At the 10th percentile in Indonesia, a actuary earns about Rp 344.502.500 while a business analyst earns about Rp 215.212.100 per year.
- How do senior-level salaries compare?
- At the 90th percentile in Indonesia, a actuary earns about Rp 742.408.100 while a business analyst earns about Rp 463.785.300 per year.
- Are actuary and business analyst similar careers?
- Both roles sit in the Finance & Business category on Pay by Role, which is why we compare them head-to-head. Day-to-day work still differs — review each job page for skills and outlook.